ArchiMed Acquires ActiGraph to Expand its Global Footing
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

ArchiMed Acquires ActiGraph to Expand its Global Footing

By Pharma Tech Outlook | Wednesday, May 20, 2020

Jeremy Wyatt, CTO & Senior VP

Global private equity healthcare specialist ArchiMed has acquired actiGraph

FREMONT, CA: ActiGraph, a renowned provider of medical-grade wearable physical activity and sleep monitoring solutions for the global scientific community, has been acquired by global private equity healthcare specialist ArchiMed.

ArchiMed and ActiGraph, both share a similar mission of helping extend people’s lives for better. ArchiMed’s investment on the ActiGraph’s employees, capabilities, and technology will allow the company to deepen the impact and value of its patient monitoring solutions portfolio to support the development of life-changing therapies.

ArchiMed’s enduring strategic expertise and guidance have placed ActiGraph in a suitable position for enhanced, continued innovation and growth in pharma and biotechnology research. The company’s digital remote monitoring platform is especially well-suited for siteless or virtual trials, which are becoming vital to lead sustained clinical study and to provide protection for the patients amid the COVID-19 pandemic.

“This acquisition is an important next step for ActiGraph and the customers we serve,” said Jeremy Wyatt, ActiGraph President, and COO. “We are excited to partner with a group that believes in our mission and supports our scale into the digital health technology industry. ArchiMed’s backing will enable us to enhance our supplier relationships, global regulatory standing, product delivery capabilities, software services, and innovative wearable sensor offerings. Doing so will ensure that we continue to deliver high-quality digital health outcomes in unique and novel ways for our customers and the patients who depend on us. I could not be proud of our employees who have worked so hard to get us to this stage. Their passion, enthusiasm, and commitment to excellence are unsurpassed.”

More recently, ActiGraph, The company listed as one of the Top 10 eClinical Trial Management Solution Providers in 2017 by Pharma Tech Outlook Magazine, started offering technology solutions to those pharmaceutical and life sciences organizations that are seeking to capture and monitor real-world physical activity, mobility, and sleep behavior for patients enrolled in clinical trials.

“ActiGraph is a well-established pioneer in wearable sensor technology, and their market-leading patient monitoring solutions exemplify digital health transformation in clinical research,” said Rick Riegel, ActiGraph Chairman of the Board. “ArchiMed’s acquisition will provide ActiGraph with the financial backing and strategic expertise required to accelerate product innovation and scale business operations to drive growth and expand the company’s global footprint.”

Weekly Brief

Read Also